Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats

American Journal of Chinese Medicine

Volumn 40, Issue 4, 2012, Pages 721-733

  Huang, Wenfan ^a   Yu, Jie ^b   Jia, Xuming ^c   Xiong, Liang ^a   Li, Ningxu ^a   Wen, Xiuying ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b First People's Hospital of Jiujiang City   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Forkhead Box O1; Glucokinase; Gluconeogenesis; Type 2 Diabetes; Zhenqing Recipe

Indexed keywords

BETA ACTIN; FORKHEAD BOX O1 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; HERBACEOUS AGENT; INSULIN; MESSENGER RNA; METFORMIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); STREPTOZOCIN; UNCLASSIFIED DRUG; ZHENQING;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG INDUCED DISEASE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HERBAL MEDICINE; INSULIN SENSITIVITY; LIVER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; RAT; TREATMENT DURATION;

ANIMALS; BASE SEQUENCE; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; DRUGS, CHINESE HERBAL; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIVER; MALE; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR;

EID: 84864256344     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500541     Document Type: Article

References (33)

1. Accili, D. and K.C. Arden. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117: 421-426, 2004. (Pubitemid 38610228)
2. Altomonte, J., A. Richter, S. Harbaran, J. Suriawinata, J. Nakae, S.N. Thung, M. Meseck, D. Accili and H. Dong. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am. J. Physiol. Endocrinol. Metab. 285: 718-728, 2003.
3. Barthel, A. and D. Schmoll. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 285: 685-692, 2003.
4. Boden, G., X. Chen and T.P. Stein. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 280: 23-30, 2001.
5. Danda, R.S., N.M. Habiba, H. Rincon-Choles, B.K. Bhandari, J.L. Barnes, H.E. Abboud and P.E. Pergola. Kidney involvement in a nongeneti crat model of type 2 diabetes. Kidney. Int. 68: 2562-2571, 2005. (Pubitemid 43251001)
6. Dong, X.C., K.D. Copps, S. Guo, Y. Li, R. Kollipara, R.A. DePinho and M.F. White. Inactivation of hepatic foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab. 8: 65-76, 2008. (Pubitemid 351863393)
7. Ganjam, G.K., E.Y. Dimova, T.G. Unterman and T. Kietzmann. FOXO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol. J. Biol. Chem. 84: 30783-30797, 2009.
8. He, K., X. Li, X. Chen, X. Ye, J. Huang, Y. Jin, P. Li, Y. Deng, Q. Jin, Q. Shi, and H. Shu. Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice. J. Ethnopharmacol. 137: 1135-1142, 2011.
9. Hirota, K., H. Daitoku, H. Matsuzaki, N. Araya, K. Yamagata, S. Asada, T. Sugaya and A. Fukamizu. Hepatocyte nuclear factor-4 is a novel downstream target of insulin via FKHR as a signal-regulated transcriptional inhibitor. J. Biol. Chem. 278: 13056-13060, 2003. (Pubitemid 36800073)
10. Hirota, K., J. Sakamaki, J. Ishida, Y. Shimamoto, S. Nishihara, N. Kodama, K. Ohta, M. Yamamoto, K. Tanimoto and A. Fukamizu. A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding. J. Biol. Chem. 47: 32432-32441, 2008.
11. Hirotsugu, T., N. Takeyuki, S. Akiyoshi, U. Yasuharu, S. Teruhiko and S. Masayuki. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice. Eur. J. Pharmacol. 645: 185-191, 2010.
12. Hundal, R.S., M. Krssak, S. Dufour, D. Laurent, V. Lebon, V. Chandramouli, S.E. Inzucchi, W.C. Schumann, K.F. Petersen, B.R. Landau and G.I. Shulman. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49: 2063-2069, 2000.
13. Kaestner, K.H., W. Knochel and D.E. Martinez. Unified nomenclature for the winged helix/forkhead transcription factors. Gene Dev. 14: 142-146, 2000. (Pubitemid 30070978)
14. Kang, L., A.A. Dunn-Meynell, V.H. Routh, L.D. Gaspers, Y. Nagata, T. Nishimura, J. Eiki, B.B. Zhang and B.E. Levin. Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes 55: 412-420, 2006. (Pubitemid 43343271)
15. Koo, S.H., H. Satoh, S. Herzig, C.H. Lee, S. Hedrick, R. Kulkarni, R.M. Evans, J. Olefsky and M. Montminy. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 10: 530-534, 2004. (Pubitemid 38667913)
16. Kumari, C.S., S. Govindasamy and E. Sukumar. Lipid lowering activity of Eclipta prostrata in experimental hyperlipidemia. J. Ethnopharmacol. 105: 332-335. 2006.
17. Li, G.W. and X.R. Pan. A new insulin-sensitivity index for epidemiological study. Chin. Med. J. 108: 55-56, 1995.
18. Magnuson, M.A., D.L. Rothman, L.D. Katz, R.G. Shulman and G.I. Shulman. Increased rate of gluconeogenesis in type II diabetes mellitus: A 13C nuclear magnetic resonance study. J. Clin. Invest. 90: 1322-1327, 1992.
19. Matsumoto, M., A. Pocai, L. Rossetti, R.A. Depinho and D. Accili. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor foxo1 in liver. Cell Metab. 6: 208-216, 2007. (Pubitemid 47336849)
20. Nakae, J., W.H. Biggs, T. Kitamura, W. Cavenee, C.V. Wright, K.C. Arden and D. Accili. Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet. 32: 245-253, 2002.
21. Pagliassotti, M.J., J. Kang, J.S. Thresher, C.K. Sung and M.E. Bizeau. Elevated basal PI-3 kinase activity and reduced insulin signaling in sucrose induced hepatic insulin resistance. Am. J. Physiol. Endocrinol. Metab. 282: 170-176, 2002.
22. Samuel, V.T., C.S. Choi, T.G. Phillips, A.J. Romanelli, J.G. Geisler, S. Bhanot, R. McKay, B. Monia, J.R. Shutter, R.A. Lindberg, G.I. Shulman and M.M. Veniant. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55: 2042-2050, 2006. (Pubitemid 44509978)
23. Sang, Z., L. Zhou, X. Fan and R.J. McCrimmon. Radix astragali (huangqi) as a treatment for defective hypoglycemia counterregulation in diabetes. Am. J. Chin. Med. 38: 1027-1038, 2010
24. Song, J., P. Ren, L. Zhang, X.L. Wang, L. Chen and Y.H. Shen. Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acidbinding protein 4. Biochem. Biophys. Res. Commun. 393: 89-94, 2010.
25. Streeper, R.S., C.A. Svitek, S. Chapman, L.E. Greenbaum, R. Taub and R.M. O'Brien. A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6- phosphatase gene transcription by insulin. J. Biol. Chem. 272: 11698-11701, 1997. (Pubitemid 27202731)
26. Wang, Z.H., C.C. Hsu, C.N. Huang and M.C. Yin. Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Eur. J. Pharmacol. 628: 255-260, 2010.
27. Wen, X.Y., L. Xiong, H. Liu and Q.H. Wang. Effect of Zhengqing Recipe in the treatment of 50 senile patients with diabetic nephropathy. Herald of Medicine 25: 782-784, 2006.
28. Wen, X.Y., W.G. Xu, L. Xiong, M.W. Xu, H. Liu, H. Zhang, Q. Luo, Q.H. Niao and L.F. Liu. Antidiabetic activity of Zhenqing Recipe and Ligustri Lucidi Fructus in type 2 diabetic rats. Chin. Herb. Med. 3: 47-53, 2011.
29. Wen, X.Y., Y.L. Zeng, L.F. Liu, H. Zhang, W.G. Xu, N.X. Li and X.M. Jia. Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c. J. Ethnopharmacol. 142: 144-150, 2012.
30. Zhang, W., S. Patil, H.B. Chau, S. Guo, D.R. Powell, J. Le, A. Klotsas, R. Matika, X. Xiao, R. Franks, K.A. Heidenreich, M.P. Sajan, R.V. Farese, D.B. Stolz, P. Tso, S.H. Koo, M. Montminy and T.G. Unterman. FOXO1 regulates multiple metabolic pathways in the liver: Effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 281: 10105-10117, 2006. (Pubitemid 43864546)
31. Zhao, X., L. Gan, H. Pan, D. Kan, M. Majeski, S.A. Adam and T.G. Unterman. Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: Characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem. J. 378: 839-849, 2004. (Pubitemid 38406861)
32. Zhen, Z., B. Chang, M. Li, F.M. Lian, L. Chen, L. Dong, J. Wang, B. Yu, W.K. Liu, X.Y. Li, P.J. Qin, J.H. Zhang and X.L. Tong. Anti-diabetic effects of a Coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats. Am. J. Chin. Med. 39: 53-63, 2011.
33. Ziv, E., R. Kalman, K. Hershkop, V. Barash, E. Shafrir and H. Bar-On. Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemic, normoinsulinemic state. Diabetologia 39: 1269-1275, 1996. (Pubitemid 26356053)